1120 jobs found in Waltham, MA

McKesson is an impact-driven organization that touches virtually every aspect of health. We are a diversified healthcare services leader dedicated to advancing health outcomes for all.

McKesson is an impact-driven organization that touches virtually every aspect of health. We are a diversified healthcare services leader dedicated to advancing health outcomes for all.

A global life sciences and healthcare company seeking answers We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all. WHAT WE DO We’re in the business of health answers. We tackle almost every known health challenge—from commonly understood and emerging viruses to life-threatening conditions and very rare diseases.  Our integrated approach means we’re able to see each idea through, full circle. Our work has helped to power clearer, more confident decisions for those dealing with some of life’s most critical choices. It’s why we promise to bring solutions to market with speed and precision—because every answer is paramount.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us. CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 270 plasma collection centers in U.S., Europe and China and employs over 12,000 employees. CSL Plasma is vertically integrated, meaning plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing and delivering its life-saving therapies to people in more than 70 countries. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia.

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).